US Stock MarketDetailed Quotes
WST West Pharmaceutical Services
- 330.050
- -1.570-0.47%
Close Dec 13 16:00 ET
- 330.050
- 0.0000.00%
Post 20:01 ET
23.90BMarket Cap48.97P/E (TTM)
330.250High324.230Low516.11KVolume329.680Open331.620Pre Close169.79MTurnover0.72%Turnover Ratio41.88P/E (Static)72.42MShares412.98952wk High8.69P/B23.74BFloat Cap264.61252wk Low0.80Dividend TTM71.92MShs Float471.827Historical High0.24%Div YieldTTM1.82%Amplitude2.978Historical Low328.984Avg Price1Lot Size
West Pharmaceutical Services Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M | -0.47%716.6M | 1.95%2.89B | -3.02%708.7M |
| Operating revenue | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M | -0.47%716.6M | 1.95%2.89B | -3.02%708.7M |
| Cost of revenue | 5.03%482.2M | 2.10%472.1M | 4.47%465.2M | 3.99%1.82B | 1.61%453.8M | 9.60%459.1M | 2.80%462.4M | 2.27%445.3M | 5.73%1.75B | 3.81%446.6M |
| Gross profit | -8.19%264.7M | -21.07%230M | -15.15%230.2M | -0.62%1.13B | 6.14%278.2M | 7.57%288.3M | -9.36%291.4M | -4.67%271.3M | -3.37%1.14B | -12.81%262.1M |
| Operating expense | -6.07%99M | -4.19%100.5M | 1.16%104.3M | 12.36%421.8M | 6.69%108.4M | 31.91%105.4M | 9.38%104.9M | 5.20%103.1M | -9.67%375.4M | -9.04%101.6M |
| Selling and administrative expenses | -6.18%83.5M | -6.11%83M | 0.81%86.7M | 11.52%353.4M | 5.02%90M | 34.24%89M | 8.47%88.4M | 3.12%86M | -12.65%316.9M | -12.55%85.7M |
| Research and development costs | -5.49%15.5M | 6.06%17.5M | 2.92%17.6M | 16.92%68.4M | 15.72%18.4M | 20.59%16.4M | 14.58%16.5M | 17.12%17.1M | 10.80%58.5M | 16.06%15.9M |
| Operating profit | -9.40%165.7M | -30.56%129.5M | -25.15%125.9M | -7.02%707.4M | 5.79%169.8M | -2.76%182.9M | -17.33%186.5M | -9.86%168.2M | 0.08%760.8M | -15.03%160.5M |
| Net non-operating interest income expense | -33.90%3.9M | 8.70%2.5M | 76.92%4.6M | 778.57%19M | 583.33%8.2M | 942.86%5.9M | 264.29%2.3M | 236.84%2.6M | 61.11%-2.8M | 152.17%1.2M |
| Non-operating interest income | -47.73%4.6M | -20.00%4M | 29.17%6.2M | 449.02%28M | 224.14%9.4M | 486.67%8.8M | 1,150.00%5M | 1,500.00%4.8M | 410.00%5.1M | 866.67%2.9M |
| Non-operating interest expense | -75.86%700K | -44.44%1.5M | -27.27%1.6M | 13.92%9M | -29.41%1.2M | 31.82%2.9M | 50.00%2.7M | 0.00%2.2M | -3.66%7.9M | -34.62%1.7M |
| Other net income (expense) | -183.33%-5.1M | 15.38%-3.3M | 75.97%-3.1M | 63.64%-28.4M | 70.30%-9.8M | 96.48%-1.8M | -230.00%-3.9M | -516.13%-12.9M | -1,804.88%-78.1M | -602.13%-33M |
| Gain on sale of security | -127.78%-4.1M | -566.67%-2M | -33.33%-1.2M | -291.07%-10.7M | -1,183.33%-7.7M | -357.14%-1.8M | -118.75%-300K | -123.08%-900K | 80.65%5.6M | -200.00%-600K |
| Special income (charges) | 107.14%300K | 61.76%-1.3M | 86.21%-1.6M | 37.27%-20.7M | 95.07%-1.5M | -44.83%-4.2M | -409.09%-3.4M | -1,350.00%-11.6M | -254.84%-33M | -473.58%-30.4M |
| -Less：Restructuring and merger&acquisition | -285.71%-1.3M | 433.33%1M | 233.33%1M | -101.87%-500K | -104.65%-1.2M | -53.33%700K | 76.92%-300K | -62.50%300K | 624.32%26.8M | 8,500.00%25.8M |
| -Less:Impairment of capital assets | ---- | ---- | -68.42%600K | ---- | ---- | ---- | ---- | --1.9M | ---- | ---- |
| -Write off | -71.43%1M | -80.00%300K | ---- | 54.84%9.6M | -41.30%2.7M | 150.00%3.5M | --1.5M | ---- | 10.71%6.2M | --4.6M |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | ---11.6M | --0 | --0 | ---2.2M | ---9.4M | --0 | --0 |
| Other non- operating income (expenses) | -130.95%-1.3M | ---- | 25.00%-300K | 105.92%3M | 70.00%-600K | 108.57%4.2M | -166.67%-200K | ---400K | -2,514.29%-50.7M | ---2M |
| Income before tax | -12.03%164.5M | -30.39%128.7M | -19.32%127.4M | 2.66%698M | 30.69%168.2M | 37.30%187M | -18.62%184.9M | -15.92%157.9M | -9.21%679.9M | -29.25%128.7M |
| Income tax | 10.20%32.4M | -37.07%21.9M | -30.51%16.4M | 6.63%122.3M | 19.38%34.5M | 44.12%29.4M | -21.27%34.8M | 11.32%23.6M | 7.00%114.7M | -15.50%28.9M |
| Earnings from equity interest net of tax | 5.41%3.9M | -10.00%4.5M | -24.56%4.3M | -14.49%17.7M | 3.13%3.3M | -22.92%3.7M | -9.09%5M | -20.83%5.7M | 2.99%20.7M | --3.2M |
| Net income | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M | -11.47%585.9M | -30.26%103M |
| Net income continuous Operations | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M | -11.47%585.9M | -30.26%103M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M | -11.47%585.9M | -30.26%103M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M | -11.47%585.9M | -30.26%103M |
| Basic earnings per share | -13.82%1.87 | -26.92%1.52 | -16.49%1.57 | 1.40%7.98 | 34.06%1.85 | 33.95%2.17 | -17.79%2.08 | -19.66%1.88 | -11.47%7.87 | -30.30%1.38 |
| Diluted earnings per share | -13.55%1.85 | -26.70%1.51 | -16.22%1.55 | 1.94%7.88 | 34.56%1.83 | 34.59%2.14 | -16.94%2.06 | -19.21%1.85 | -10.84%7.73 | -29.53%1.36 |
| Dividend per share | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 5.48%0.77 | 5.26%0.2 | 5.56%0.19 | 5.56%0.19 | 5.56%0.19 | 5.80%0.73 | 5.56%0.19 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data